RATIONALE: The use of dried blood spots (DBS) has many advantages over traditional plasma and serum samples such as the smaller blood volume required, storage at room temperature, and ability to sample in remote locations. However, understanding the robustness of different analytes in DBS samples is essential, especially in older samples collected for longitudinal studies. METHODS: Here we analyzed the stability of polar metabolites and lipids in DBS samples collected in 2000-2001 and stored at room temperature. The identified and statistically significant molecules were then compared to matched serum samples stored at -80°C to determine if the DBS samples could be effectively used in a longitudinal study following metabolic disease. RESULTS: A total of 400 polar metabolites and lipids were identified in the serum and DBS samples using gas chromatograph/mass spectrometry (GC/MS), liquid chromatography (LC)/MS, and LC/ion mobility spectrometry-MS (LC/IMS-MS). The identified polar metabolites overlapped well between the sample types, though only one statistically significant metabolite was conserved in a case-control study of older diabetic males with low amounts of high-density lipoproteins and high body mass indices, triacylglycerides and glucose levels when compared to non-diabetic patients with normal levels, indicating that degradation in the DBS samples affects polar metabolite quantitation. Differences in the lipid identifications indicated that some oxidation occurs in the DBS samples. However, 36 statistically significant lipids correlated in both sample types. CONCLUSIONS: The difference in the number of statistically significant polar metabolites and lipids indicated that the lipids did not degrade to as great of a degree as the polar metabolites in the DBS samples and lipid quantitation was still possible.
RATIONALE: The use of dried blood spots (DBS) has many advantages over traditional plasma and serum samples such as the smaller blood volume required, storage at room temperature, and ability to sample in remote locations. However, understanding the robustness of different analytes in DBS samples is essential, especially in older samples collected for longitudinal studies. METHODS: Here we analyzed the stability of polar metabolites and lipids in DBS samples collected in 2000-2001 and stored at room temperature. The identified and statistically significant molecules were then compared to matched serum samples stored at -80°C to determine if the DBS samples could be effectively used in a longitudinal study following metabolic disease. RESULTS: A total of 400 polar metabolites and lipids were identified in the serum and DBS samples using gas chromatograph/mass spectrometry (GC/MS), liquid chromatography (LC)/MS, and LC/ion mobility spectrometry-MS (LC/IMS-MS). The identified polar metabolites overlapped well between the sample types, though only one statistically significant metabolite was conserved in a case-control study of older diabetic males with low amounts of high-density lipoproteins and high body mass indices, triacylglycerides and glucose levels when compared to non-diabeticpatients with normal levels, indicating that degradation in the DBS samples affects polar metabolite quantitation. Differences in the lipid identifications indicated that some oxidation occurs in the DBS samples. However, 36 statistically significant lipids correlated in both sample types. CONCLUSIONS: The difference in the number of statistically significant polar metabolites and lipids indicated that the lipids did not degrade to as great of a degree as the polar metabolites in the DBS samples and lipid quantitation was still possible.
Authors: Sunil S Solomon; Suniti Solomon; Irma I Rodriguez; Stephen T McGarvey; A K Ganesh; S P Thyagarajan; Anish P Mahajan; Kenneth H Mayer Journal: Int J STD AIDS Date: 2002-01 Impact factor: 1.359
Authors: Melissa M Matzke; Katrina M Waters; Thomas O Metz; Jon M Jacobs; Amy C Sims; Ralph S Baric; Joel G Pounds; Bobbie-Jo M Webb-Robertson Journal: Bioinformatics Date: 2011-08-18 Impact factor: 6.937
Authors: Ernesto S Nakayasu; Carrie D Nicora; Amy C Sims; Kristin E Burnum-Johnson; Young-Mo Kim; Jennifer E Kyle; Melissa M Matzke; Anil K Shukla; Rosalie K Chu; Athena A Schepmoes; Jon M Jacobs; Ralph S Baric; Bobbie-Jo Webb-Robertson; Richard D Smith; Thomas O Metz Journal: mSystems Date: 2016-05-10 Impact factor: 6.496
Authors: Bobbie-Jo M Webb-Robertson; Kelly G Stratton; Jennifer E Kyle; Young-Mo Kim; Lisa M Bramer; Katrina M Waters; David M Koeller; Thomas O Metz Journal: Anal Chem Date: 2019-12-05 Impact factor: 6.986
Authors: Berwyck L J Poad; Xueyun Zheng; Todd W Mitchell; Richard D Smith; Erin S Baker; Stephen J Blanksby Journal: Anal Chem Date: 2017-12-21 Impact factor: 6.986
Authors: Jennifer E Kyle; Noor Aly; Xueyun Zheng; Kristin E Burnum-Johnson; Richard D Smith; Erin S Baker Journal: Bioanalysis Date: 2018-03-01 Impact factor: 2.681
Authors: Helena Beatriz Ferreira; Inês M S Guerra; Tânia Melo; Hugo Rocha; Ana S P Moreira; Artur Paiva; M Rosário Domingues Journal: Anal Bioanal Chem Date: 2022-07-15 Impact factor: 4.478
Authors: Alex J Thompson; Claire D Bourke; Ruairi C Robertson; Nirupama Shivakumar; Christine A Edwards; Tom Preston; Elaine Holmes; Paul Kelly; Gary Frost; Douglas J Morrison Journal: Gut Date: 2021-06-08 Impact factor: 23.059